Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
1 Skeletal Muscle Allogeneic – Related Duchenne Muscular Dystrophy (DMD) Genetic Disorder 2026 Experimental Therapy Poland 14
2 Skeletal Muscle Allogeneic – Related Dystrophia Progressiva Pseudohypertrophica/DMD Genetic Disorders 2026 Experimental Therapy Poland no data
3 Skeletal Muscle Allogeneic – Related Dystrophia Progressiva Pseudohypertrophica/DMD Genetic Disorders 2026 Experimental Therapy Poland no data
4 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 4
5 Cord Tissue Autologous Autism Neurology 2026 Experimental Therapy Slovakia 4
6 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 7,11
7 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 5,3
8 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 7,11
9 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 3,11
10 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2026 Experimental Therapy Poland 67,2
11 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2026 Experimental Therapy Poland 50,7
12 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 4,6
13 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 6,5
14 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 6,7
15 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 6,5
16 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2026 Experimental Therapy Poland 2,9
17 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2026 Experimental Therapy Poland 3,1
18 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedics 2026 Experimental Therapy Poland 60,7
19 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2026 Experimental Therapy Poland 5,5
20 Cord Tissue Allogeneic Autism Neurology 2026 Experimental Therapy United Arab Emirates 6
21 Cord Tissue Allogeneic – Unrelated GvHD Hematology 2026 Experimental Therapy Poland 4,1
22 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2026 Experimental Therapy Poland 4,9
23 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 8,7
24 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2026 Experimental Therapy Poland 3,2
25 Cord Tissue Autologous Cerebral Palsy Neurology 2026 Experimental Therapy Slovakia 2
26 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 6
27 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 13
28 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 8
29 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 9
30 Cord Tissue Autologous Autism Neurology 2026 Experimental Therapy Slovakia 8
31 Cord Tissue Autologous Autism Neurology 2026 Experimental Therapy Slovakia 5
32 Cord Tissue Autologous Autism Neurology 2026 Experimental Therapy Slovakia 3
33 Cord Tissue Allogeneic – Related Autism Neurology 2026 Experimental Therapy Slovakia 3
34 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 7,1
35 Cord Tissue Allogeneic – Unrelated Optic Atrophy Ophthalmology 2026 Experimental Therapy Poland 76,3
36 Cord Tissue Allogeneic – Unrelated Encephalitis, Myelitis Neurology 2026 Experimental Therapy Poland 36,6
37 Cord Tissue Allogeneic – Unrelated Stress Incontinence Urology 2026 Experimental Therapy Poland 62,4
38 Cord Tissue Allogeneic – Unrelated aGvHD, PNH Hematology 2026 Experimental Therapy Poland 17,8
39 Cord Tissue Allogeneic – Unrelated Progressive Bulbar Palsy Neurology 2026 Experimental Therapy Poland 58,1
40 Cord Tissue Allogeneic – Unrelated Autism Neurology 2026 Experimental Therapy Poland 6,2
41 Cord Tissue Allogeneic – Unrelated Spinocerebellar Ataxia Neurology 2026 Experimental Therapy Poland 59,4
42 Cord Tissue Allogeneic – Unrelated aGvHD Hematology 2026 Experimental Therapy Poland 15,5
43 Cord Tissue Allogeneic – Unrelated aGvHD Hematology 2026 Experimental Therapy Poland 12,1
44 Cord Tissue Allogeneic – Unrelated aGvHD Hematology 2026 Experimental Therapy Poland 10
45 Cord Tissue Allogeneic – Unrelated MSA, Multiple System Atrophy Neurology 2026 Experimental Therapy Centrum Medyczne Klara Częstochowa 53,1
46 Cord Tissue Allogeneic – Unrelated Stress Incontinence Gynecology 2026 Experimental Therapy Szpital Uniwersytecki w Krakowie ul. Mikołaja Kopernika 79,11
47 Cord Tissue Allogeneic – Unrelated Progressive Bulbar Palsy Neurology 2026 Experimental Therapy Centrum Medyczne Klara Częstochowa 65,1
48 Cord Tissue Allogeneic – Unrelated MSA, Multiple System Atrophy Neurology 2026 Experimental Therapy Centrum Medyczne Klara Częstochowa 61,3
49 Cord Tissue Allogeneic Related Spondylosis + Lumbar Disc Disease Rheumatology 2026 Experimental Therapy Slovakia , Malacky 32
50 Cord Tissue Autologus Autism Neurology 2026 Experimental Therapy Slovakia , Malacky 3
51 Cord Tissue Allogeneic – Unrelated Cartilage Lesions Orthopedy 2026 Experimental Therapy Poland 64,1
52 Cord Tissue Allogeneic – Unrelated Stress Incontinence Gynecology 2026 Experimental Therapy Poland 75,6
53 Cord Tissue Allogeneic – Unrelated Polyneuropathy Neurology 2026 Experimental Therapy Poland 27,1
54 Cord Tissue Allogeneic – Unrelated Acute And Chronic Graft-Versus-Host-Disease aGVHD And cGVHD Hematology 2026 Experimental Therapy Poland 17,11
55 Cord Tissue Allogeneic – Unrelated Acute and chronic Graft-versus-Host-Disease aGvHD and cGvHD Hematology 2026 Experimental Therapy Poland 3,7
56 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 4,6
57 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 8,9
58 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 5,2
59 Cord Blood Allogeneic – Unrelated Acute Leukemia in remission, Pancytopenia after treatment Hematology 2026 Standard Therapy Denmark 18, 6
60 Cord Blood Allogeneic – Related Juvenile Myelomonocytic Leukemia (JMML) Hematology 2026 Standard Therapy Germany 10, 10
61 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 6,9
62 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 7,2
63 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 5,5
64 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 4,1
65 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 8,6
66 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 7,6
67 Cord Blood Allogeneic Thalassemia Major Hematology 2026 Standard Therapy Turkey 7,8
68 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 8,9
69 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 4,5
70 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 3,5
71 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 8
72 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 5
73 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 3
74 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 6,5
75 Cord Blood Allogeneic – Related Diamond-Blackfan Anemia (DBA) Hematology 2026 Standard Therapy Germany 10, 1
76 Cord Blood Autologus Autism Neurology 2026 Experimental Therapy Poland, Lublin, Uniwersytecki Szpital Kliniczny 7,11
77 Cord Blood Autologus Autism Neurology 2026 Experimental Therapy Poland, Lublin, Uniwersytecki Szpital Kliniczny 7,4
78 Cord Blood Autologus Autism Neurology 2026 Experimental Therapy Slovakia , Malacky 3
79 Cord Blood Allogeneic – Related Thalassemia Beta Hematology 2026 Standard therapy Turkey 8 years 11 months
80 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 5
81 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 11
82 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Slovakia 6
83 Cord Blood Autologous Autism Neurology 2026 Experimental Therapy Poland 7,2
84 Bone Marrow Family Allogeneic T-Cell Lymphoma Hematology 2026 Standard Therapy Netherlands 65
85 Bone Marrow Family Allogeneic Other Malignancy Hematology 2026 Standard Therapy France 51
86 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Italy 27
87 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 14
88 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy France 68
89 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy United Kingdom 43
90 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 68
91 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 69
92 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Germany 67
93 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy USA 64
94 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 73
95 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy United Kingdom 26
96 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy USA 74
97 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Netherlands 66
98 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2026 Standard Therapy Romania 25
99 Bone Marrow Family Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2026 Standard Therapy USA 65
100 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2026 Standard Therapy Poland 62